Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infection in Patients With Obesity or Diabetes: A Subgroup Analysis of Pooled Phase 3 Clinical Trials

BACKGROUND: We assessed the efficacy and safety of dalbavancin, a long-acting lipoglycopeptide with activity against Gram-positive pathogens, for treatment of acute bacterial skin and skin structure infections (ABSSSI) in patients with high body mass index (BMI) and/or diabetes. METHODS: Data from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccobene, Todd, Lock, John, Lyles, Rosie D, Georgiades, Benjamin, Nowak, Michael, Gonzalez, Pedro L, Park, Jenny, Rappo, Urania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249272/
https://www.ncbi.nlm.nih.gov/pubmed/37305839
http://dx.doi.org/10.1093/ofid/ofad256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249272/
https://www.ncbi.nlm.nih.gov/pubmed/37305839
http://dx.doi.org/10.1093/ofid/ofad256

Ejemplares similares